Review




Structured Review

Proteintech anti rpa2
MiR-139-3p targets <t>RPA2</t> to enhance DNA damage sensitivity in breast cancer cells. (A) Venn diagram of the miR-139-3p target genes and DSB response genes. (B) The relative messenger RNA level of five potential targets in the miR-139-3p in MDA-MB-231 and MCF-7 cells transfected with NC or miR-139-3p mimics. (C) Western blot of RPA2 in the cells transfected with NC or miR-139-3p mimics. (D) The relative Firefly/Renilla luciferase activity in the 293T cells transfected with the luciferase vector containing wt or mut RPA2 3’UTR luciferase plasmids, and NC or miR-139-3p mimics. (E) Stable overexpression of RPA2 -3Flag in BC cells. (F,G) IR colony formation ability of the (F) MDA-MB-231 and (G) MCF-7 cells stably overexpressing RPA2 and transfected with miR-139-3p mimics and stained with crystal violet. 1× magnification. (H,I) Cisplatin sensitivity MTS assays of the (H) MDA-MB-231 and (I) MCF-7 cells in different groups. (J) Schematic of HR repair reporter assays (upper). The HR repair efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with siBRCA1 as a positive control. (K) Schematic of NHEJ reporter assays (upper). The NHEJ efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with si53BP1 as a positive control. (L) gH2AX foci immunostained for gH2AX (green) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. The gH2AX foci numbers were counted from a minimum of 150 cells. Scale bar: 10 μm. (M) RAD51 foci in the S phase immunostained for RAD51 (red) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. RAD51 foci numbers were counted from a minimum of 150 cells. Scale bar: 10 mm. ns, non-significant; *, P<0.05; **, P<0.01; ***, P<0.001. DAPI, 4’,6-diamidino-2-phenylindole; DSB, double-strand break; GEP, gene editing plasmid; GFP, green fluorescent protein; gH2AX, phosphorylated H2AX; HR, homologous recombination; iGFP, internal GFP reporter; IR, irradiation; mut, mutant type; NC, negative control; NHEJ, non-homologous end joining; wt, wild type; UTR, untranslated region.
Anti Rpa2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 50 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/RPA2+Antibody/pmc12885918-125-16-18
Average 93 stars, based on 50 article reviews
anti rpa2 - by Bioz Stars, 2026-11
93/100 stars

Images

1) Product Images from "A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents"

Article Title: A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents

Journal: Translational Cancer Research

doi: 10.21037/tcr-2025-1-2592

MiR-139-3p targets RPA2 to enhance DNA damage sensitivity in breast cancer cells. (A) Venn diagram of the miR-139-3p target genes and DSB response genes. (B) The relative messenger RNA level of five potential targets in the miR-139-3p in MDA-MB-231 and MCF-7 cells transfected with NC or miR-139-3p mimics. (C) Western blot of RPA2 in the cells transfected with NC or miR-139-3p mimics. (D) The relative Firefly/Renilla luciferase activity in the 293T cells transfected with the luciferase vector containing wt or mut RPA2 3’UTR luciferase plasmids, and NC or miR-139-3p mimics. (E) Stable overexpression of RPA2 -3Flag in BC cells. (F,G) IR colony formation ability of the (F) MDA-MB-231 and (G) MCF-7 cells stably overexpressing RPA2 and transfected with miR-139-3p mimics and stained with crystal violet. 1× magnification. (H,I) Cisplatin sensitivity MTS assays of the (H) MDA-MB-231 and (I) MCF-7 cells in different groups. (J) Schematic of HR repair reporter assays (upper). The HR repair efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with siBRCA1 as a positive control. (K) Schematic of NHEJ reporter assays (upper). The NHEJ efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with si53BP1 as a positive control. (L) gH2AX foci immunostained for gH2AX (green) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. The gH2AX foci numbers were counted from a minimum of 150 cells. Scale bar: 10 μm. (M) RAD51 foci in the S phase immunostained for RAD51 (red) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. RAD51 foci numbers were counted from a minimum of 150 cells. Scale bar: 10 mm. ns, non-significant; *, P<0.05; **, P<0.01; ***, P<0.001. DAPI, 4’,6-diamidino-2-phenylindole; DSB, double-strand break; GEP, gene editing plasmid; GFP, green fluorescent protein; gH2AX, phosphorylated H2AX; HR, homologous recombination; iGFP, internal GFP reporter; IR, irradiation; mut, mutant type; NC, negative control; NHEJ, non-homologous end joining; wt, wild type; UTR, untranslated region.
Figure Legend Snippet: MiR-139-3p targets RPA2 to enhance DNA damage sensitivity in breast cancer cells. (A) Venn diagram of the miR-139-3p target genes and DSB response genes. (B) The relative messenger RNA level of five potential targets in the miR-139-3p in MDA-MB-231 and MCF-7 cells transfected with NC or miR-139-3p mimics. (C) Western blot of RPA2 in the cells transfected with NC or miR-139-3p mimics. (D) The relative Firefly/Renilla luciferase activity in the 293T cells transfected with the luciferase vector containing wt or mut RPA2 3’UTR luciferase plasmids, and NC or miR-139-3p mimics. (E) Stable overexpression of RPA2 -3Flag in BC cells. (F,G) IR colony formation ability of the (F) MDA-MB-231 and (G) MCF-7 cells stably overexpressing RPA2 and transfected with miR-139-3p mimics and stained with crystal violet. 1× magnification. (H,I) Cisplatin sensitivity MTS assays of the (H) MDA-MB-231 and (I) MCF-7 cells in different groups. (J) Schematic of HR repair reporter assays (upper). The HR repair efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with siBRCA1 as a positive control. (K) Schematic of NHEJ reporter assays (upper). The NHEJ efficiency of the miR-139-3p overexpression group and the co-overexpression of the RPA2 group were measured by flow cytometry, with si53BP1 as a positive control. (L) gH2AX foci immunostained for gH2AX (green) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. The gH2AX foci numbers were counted from a minimum of 150 cells. Scale bar: 10 μm. (M) RAD51 foci in the S phase immunostained for RAD51 (red) and counterstained with DAPI (blue) at 12 hours post-IR in the MDA-MB-231 cells. RAD51 foci numbers were counted from a minimum of 150 cells. Scale bar: 10 mm. ns, non-significant; *, P<0.05; **, P<0.01; ***, P<0.001. DAPI, 4’,6-diamidino-2-phenylindole; DSB, double-strand break; GEP, gene editing plasmid; GFP, green fluorescent protein; gH2AX, phosphorylated H2AX; HR, homologous recombination; iGFP, internal GFP reporter; IR, irradiation; mut, mutant type; NC, negative control; NHEJ, non-homologous end joining; wt, wild type; UTR, untranslated region.

Techniques Used: Transfection, Western Blot, Luciferase, Activity Assay, Plasmid Preparation, Over Expression, Stable Transfection, Staining, Flow Cytometry, Positive Control, Homologous Recombination, Irradiation, Mutagenesis, Negative Control, Non-Homologous End Joining

The efficacy of the combination of miR-139-3p and cisplatin in vivo . (A) Schematic diagram of the construction and treatment of the xenograft model in the BALB/c nude mice. (B) Representative images of nude mice with xenograft tumors in each group. (C) Growth curve of xenograft tumors in nude mice from different groups. (D) IHC staining and analysis of the RPA2 protein in xenograft tumor. 20× magnification. (E) IHC staining and analysis of the Ki-67 protein in xenograft tumors. 1× magnification. *, P<0.05; **, P<0.01; ***, P<0.001. IHC, immunohistochemistry; NC, negative control; PBS, phosphate-buffered saline.
Figure Legend Snippet: The efficacy of the combination of miR-139-3p and cisplatin in vivo . (A) Schematic diagram of the construction and treatment of the xenograft model in the BALB/c nude mice. (B) Representative images of nude mice with xenograft tumors in each group. (C) Growth curve of xenograft tumors in nude mice from different groups. (D) IHC staining and analysis of the RPA2 protein in xenograft tumor. 20× magnification. (E) IHC staining and analysis of the Ki-67 protein in xenograft tumors. 1× magnification. *, P<0.05; **, P<0.01; ***, P<0.001. IHC, immunohistochemistry; NC, negative control; PBS, phosphate-buffered saline.

Techniques Used: In Vivo, Immunohistochemistry, Negative Control, Saline

Related Articles

other:

Article Title: TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer
Article Snippet: Cells were lysed by RIPA (Beyotime, P0013B, China), following with centrifuging at 4 °C for 10 min, and the supernatants were collected.

Immunohistochemistry:

Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress
Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; γH2AX (05-636, for WB) from Millipore; LAP2α (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; β-actin (AC004, for WB) from Abclonal; RPA2 (10412-1-AP, for WB) from Proteintech; 53BP1 (NB100-304, for IF) from NOVUS; IdU/BrdU (347580, for IF) from BD Bioscience; H2AX (YT2155, for WB) from Immunoway; and LAP2α (IQ175, for mouse tissue IHC) from ImmuQuest. .. Hydroxyurea (H8627), IdU (I7125), CldU (C6891), DAPI (F6057), and 4-OHT (H6278) were purchased from Sigma.

Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress.
Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; H2AX (05-636, for WB) from Millipore; LAP2 (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; -actin (AC004, for WB) from Abclonal; RPA2 (10412-1-AP, for WB) from Proteintech; 53BP1 (NB100-304, for IF) from NOVUS; IdU/BrdU (347580, for IF) from BD Bioscience; H2AX (YT2155, for WB) from Immunoway; and LAP2 (IQ175, for mouse tissue IHC) from ImmuQuest. .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; H2AX (05-636, for WB) from Millipore; LAP2 (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; -actin (AC004, for WB) from Abclonal; RPA2 (10412-1-AP, for WB) from Proteintech; 53BP1 (NB100-304, for IF) from NOVUS; IdU/BrdU (347580, for IF) from BD Bioscience; H2AX (YT2155, for WB) from Immunoway; and LAP2 (IQ175, for mouse tissue IHC) from ImmuQuest.

Western Blot:

Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress
Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; γH2AX (05-636, for WB) from Millipore; LAP2α (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; β-actin (AC004, for WB) from Abclonal; RPA2 (10412-1-AP, for WB) from Proteintech; 53BP1 (NB100-304, for IF) from NOVUS; IdU/BrdU (347580, for IF) from BD Bioscience; H2AX (YT2155, for WB) from Immunoway; and LAP2α (IQ175, for mouse tissue IHC) from ImmuQuest. .. Hydroxyurea (H8627), IdU (I7125), CldU (C6891), DAPI (F6057), and 4-OHT (H6278) were purchased from Sigma.

Article Title: LAP2α drives breast tumorigenesis by mitigating replication stress.
Article Snippet: .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; H2AX (05-636, for WB) from Millipore; LAP2 (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; -actin (AC004, for WB) from Abclonal; RPA2 (10412-1-AP, for WB) from Proteintech; 53BP1 (NB100-304, for IF) from NOVUS; IdU/BrdU (347580, for IF) from BD Bioscience; H2AX (YT2155, for WB) from Immunoway; and LAP2 (IQ175, for mouse tissue IHC) from ImmuQuest. .. The sources of antibodies against the following proteins or post-translational modifications were as follows: γH2AX (9718S, for IHC), CHK1 pS345 (2341S, for WB) and CHK1 (2360S, for WB), from Cell Signaling Technology; RPA2 pS33 (A300-246A, for WB) from Bethly Lab; FLAG (F3165, for WB) from Sigma; H2AX (05-636, for WB) from Millipore; LAP2 (ab5162, for WB and human tissue IHC), Ki-67 (ab16667, for mouse tissue IHC), CldU/BrdU (ab6326, for IF), RPA2 (ab2175, for WB and IF), and RPA1 (ab176467, for WB) from Abcam; -actin (AC004, for WB) from Abclonal; RPA2 (10412-1-AP, for WB) from Proteintech; 53BP1 (NB100-304, for IF) from NOVUS; IdU/BrdU (347580, for IF) from BD Bioscience; H2AX (YT2155, for WB) from Immunoway; and LAP2 (IQ175, for mouse tissue IHC) from ImmuQuest.

Proximity Ligation Assay:

Article Title: TTK activates ATR through RPA2 phosphorylation to promote olaparib resistance in ovarian cancer
Article Snippet: The LC-MS/MS analysis was performed by Applied Protein Technology (Shanghai, China). .. For PLA assay, TTK (1:100, abcam; ab11108) and RPA2(1:100; proteintech; 10412-1-AP) antibodies were added overnight at 4 °C. .. For immunofluorescence assay, the cells were incubated with γH2AX (1:100, Abcam; ab26350) alone or RAD51 (1:100, Abcam; ab133534) along with PCNA (1:100, proteintech;10205-2-AP) overnight at 4 °C.



Similar Products

97
New England Biolabs orthogonal replication machinery
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Orthogonal Replication Machinery, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/BsaI-HFv2/bio_rxiv__64898__2026__09__28__754915-133-12-23
Average 97 stars, based on 1 article reviews
orthogonal replication machinery - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

95
Agilent technologies replicate analyses
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Replicate Analyses, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/Bio+LC/10__1007_slash_s10989___026___10866___8-76-13-18
Average 95 stars, based on 1 article reviews
replicate analyses - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Illumina Inc ms replication chip
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Ms Replication Chip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/Infinium+Exome-24%2B+v1%2E1+Kit/pmc13691679-94-5-9
Average 94 stars, based on 1 article reviews
ms replication chip - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Sawai Pharmaceutical oitv replicates
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Oitv Replicates, supplied by Sawai Pharmaceutical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/oitv+replicates/pm42309469-198-0-20
Average 86 stars, based on 1 article reviews
oitv replicates - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Moderna conventional non replicating mrna based therapeutics
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Conventional Non Replicating Mrna Based Therapeutics, supplied by Moderna, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/messenger+mrna+rna+vaccines/pmc13264025-10-0-14
Average 86 stars, based on 1 article reviews
conventional non replicating mrna based therapeutics - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Hasegawa Co Ltd replication evidence
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Replication Evidence, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/evidence+replication+structural/pmc13260784-159-24-15
Average 86 stars, based on 1 article reviews
replication evidence - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mendeley Ltd replication codes
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Replication Codes, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/codes+replication/pm42269350-519-0-4
Average 86 stars, based on 1 article reviews
replication codes - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Boekel Scientific 96 pin replicator
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
96 Pin Replicator, supplied by Boekel Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/96+pin+replicator/10__3390_slash_ddc5020036-156-14-16
Average 86 stars, based on 1 article reviews
96 pin replicator - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Bavarian Nordic replication
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Replication, supplied by Bavarian Nordic, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/incompetent+replication/10__1016_slash_s1473___3099_ascii40_26_ascii41_00177___5-33-5-8
Average 86 stars, based on 1 article reviews
replication - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

94
MedChemExpress replication
(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA <t>replication:</t> the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for <t>orthogonal</t> plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.
Replication, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication/Sulindac/pm42210694-57-20-25
Average 94 stars, based on 1 article reviews
replication - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


(a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA replication: the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for orthogonal plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.

Journal: bioRxiv

Article Title: PRIME: A modular plasmid-based platform for continuous in vivo evolution across bacteria

doi: 10.64898/2026.09.28.754915

Figure Lengend Snippet: (a) The PRD1 bacteriophage possesses a 14927 bp genome encoding four proteins involved in protein-primed DNA replication: the DNA polymerase P1, the terminal protein P8, and the single-stranded DNA-binding proteins P12 and P19. (b) PRIME comprises four plasmids: pORM ( O rthogonal R eplication M achinery), pOTH ( O rthogonal T ransformation H elper), pORFITR ( O rthogonal R eplicons F lanked by Inverted T erminal R epeats), and lopEG ( L inear O rthogonal P lasmid with E volving G enes). The pORM plasmid carries the genes required for protein-primed DNA replication under control of the inducible P Cin promoter. P12_T2 and P19 are indicated in brackets, as these proteins are dispensable for orthogonal plasmid replication but are present in the pORM_P12_T2 construct. pORM additionally contains the broad-host-range pBBR1 origin of replication, enabling propagation in a wide range of bacterial hosts. The pOTH plasmid encodes accessory proteins facilitating lopEG transformation. Owing to their toxicity, these proteins are expressed under control of the inducible P BAD promoter. The temperature-sensitive pSC101(ts) origin enables efficient curing of pOTH following lopEG establishment. The pORFITR plasmid facilitates cloning and production of lopEG plasmids. It contains two inverted terminal repeat (ITR) regions flanked by MlyI recognition sites. As a Type IIS restriction enzyme, MlyI cleaves outside of its recognition sequence, enabling blunt cleavage precisely at the edges of the ITRs. The R6K conditional origin of replication prevents plasmid propagation in cells lacking the Pir protein, allowing direct transformation of lopEG plasmids without gel purification. (c) Workflow for establishment of orthogonal plasmids in E. coli . (1) Cells are first transformed with pORM and pOTH. (2) Expression of the replication proteins is induced, and the temperature is increased prior to lopEG transformation to inhibit further replication of pOTH. (3) lopEG plasmids are electroporated into competent cells expressing the PRD1 replication machinery. Orthogonal plasmid copy number can subsequently be tuned using the OHC14-HSL inducer. (d) PRIME enables continuous directed evolution experiments. Replacement of the wild-type P1 polymerase (green) with an error-prone variant (red) promotes the generation of DNA libraries directly in vivo without the need for repeated manual intervention. Iterative cycles of diversification and selection subsequently enable the rapid evolution of constructs with improved properties.

Article Snippet: The YFP gene was then replaced with the operon encoding for the orthogonal replication machinery by digestion with BsaI-HF-v2 and KpnI-HF restriction enzymes (New England Biolabs) and ligation with a similarly digested insert, yielding pORM_P12_P19.

Techniques: DNA Binding Assay, Plasmid Preparation, Control, Construct, Transformation Assay, Toxicity, Cloning, Sequencing, Gel Purification, Expressing, Variant Assay, In Vivo, Selection, Protein Binding